Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Intranasal S0597 in Environmental Exposure Chamber Model of Seasonal Allergic Rhinitis
2012-001613-16Phase 2Completed
- Sponsor
- Sun Pharma Advanced Research Company
- Start
- Apr 2012
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing S0597 intranasal with Placebo intranasal (2 arms). Primary endpoint: Change in Total Nasal Symptom Score (TNSS). Started Apr 2012; status: completed.
02
Drugs
SPARC1316
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2012-001613-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001613-16.